Structure

InChI Key NSKJTUFFDRENDM-UHFFFAOYSA-N
Smile NCCS.O=C(O)C(O)C(O)C(=O)O
InChI
InChI=1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2

Physicochemical Descriptors

Property Name Value
Molecular Formula C6H13NO6S
Molecular Weight 227.24
AlogP -0.13
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 1.0
Polar Surface Area 26.02
Molecular species BASE
Aromatic Rings 0.0
Heavy Atoms 4.0

Pharmacology

Action Mechanism of Action Reference
REDUCING AGENT Cystine reducing agent DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Non-alcoholic Fatty Liver Disease 2 D065626 ClinicalTrials
Mitochondrial Diseases 2 D028361 ClinicalTrials
Asthma 1 D001249 ClinicalTrials

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Gastrointestinal disorders
17.31
General disorders and administration site conditions
10.12
Skin and subcutaneous tissue disorders
7.24
Nervous system disorders
6.83
Musculoskeletal and connective tissue disorders
6.51
Injury, poisoning and procedural complications
6.49
Investigations
6.23
Metabolism and nutrition disorders
5.29
Infections and infestations
5.24
Vascular disorders
4.64
Renal and urinary disorders
3.61
Psychiatric disorders
3.41
Respiratory, thoracic and mediastinal disorders
2.81
Immune system disorders
2.09
Surgical and medical procedures
2.09

Cross References

Resources Reference
ChEBI 50386
ChEMBL CHEMBL2062263
FDA SRS QO84GZ3TST
KEGG C01678
PDB DHL
PubChem 11958147
SureChEMBL SCHEMBL49513
ZINC ZINC08034121